Publications by authors named "C Mebus"

Claim this Profile
A
Association between serum interleukin-17A and clinical response to tofacitinib and etanercept in moderate to severe psoriasis.
L Fitz, W Zhang, C Soderstrom, S Fraser, J Lee, C A Mebus

Clin Exp Dermatol· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Unilateral sagittal split ramus osteotomy: an alternative for some cases of asymmetric mandibular prognathism.
R Fariña, C Mebus, C Mayer, R Torrealba, E Moreno

Int J Oral Maxillofac Surg· May 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetic and safety profile of tofacitinib in children with polyarticular course juvenile idiopathic arthritis: results of a phase 1, open-label, multicenter study.
Nicolino Ruperto, Hermine I Brunner, Zbigniew Zuber, Nikolay Tzaribachev, Daniel J Kingsbury, Charles A Mebus

Pediatr Rheumatol Online J· December 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Improved disease activity with fosdagrocorat (PF-04171327), a partial agonist of the glucocorticoid receptor, in patients with rheumatoid arthritis: a Phase 2 randomized study.
Thomas Stock, Dona Fleishaker, Xin Wang, Arnab Mukherjee, Charles Mebus

Int J Rheum Dis· August 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Estimated medical expenditure and risk of job loss among rheumatoid arthritis patients undergoing tofacitinib treatment: post hoc analyses of two randomized clinical trials.
Regina Rendas-Baum, Mark Kosinski, Amitabh Singh, Charles A Mebus, Bethany E Wilkinson

Rheumatology (Oxford)· August 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis